SOX4 and myeloid leukemia: For example, in one study, 73% of mice developed myeloid leukemia after receiving a transplant of MSCV-Sox4-infected marrow, whereas none of the control mice developed leukemia.25 Other reports have also found that Sox4 leads to myeloid malignancies in mouse model as follows.